IndiaOne Finance - Company Dashboard

Governance Classic Home

Medico Remedies LtdPharmaceuticalsINE630Y01024Standalone₹35.01-1.18 (-3.26%)Jun-26

Valuation

Market Cap₹289.53 Cr

TTM PE20.89x

Forward PE19.24x

PEG4.15

Book Value₹9.10

P/B3.84x

TTM EPS₹1.67

Fwd EPS₹1.81

TTM Revenue₹237.53 Cr

TTM PAT₹13.82 Cr

TTM EBITDA₹17.50 Cr

TTM EBIT₹14.46 Cr

Last Qtr PAT₹2.52 Cr

Last Qtr EBITDA₹3.30 Cr

Last Qtr EBIT₹2.58 Cr

Profitability

ROE18.31%

ROCE22.00%

TTM NPM5.82%

TTM EBITDA %7.37%

Curr OPM3.57%

Last OPM9.82%

Curr NPM—

Last NPM—

Curr EPS₹0.30

Last EPS₹0.71

Balance sheet

Equity₹16.60 Cr

Reserve₹58.88 Cr

Total Debt₹18.84 Cr

D/E0.25x

Interest %16.27%

Curr Interest₹0.41 Cr

Price / range

Close₹34.89

vs 52W High-38.25%

vs 52W Low+12.55%

MA50—

MA200—

Returns

1D-3.99%

1W-4.68%

1M-18.09%

3M-18.32%

6M-9.18%

1Y-10.08%

2Y-26.44%

3Y-50.13%

5Y+88.59%

Diwali-28.93%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1837.30	₹4.41L Cr	148.17	3.58%
DIVISLAB	9375.00	₹2.49L Cr	84.62	17.55%
TORNTPHARM	4840.00	₹1.84L Cr	78.80	25.43%
ZYDUSLIFE	1160.00	₹1.16L Cr	33.21	12.96%
CIPLA	1394.50	₹1.13L Cr	36.64	8.93%
LAURUSLABS	1954.00	₹1.06L Cr	120.92	16.46%
AUROPHARMA	1734.00	₹99.77K Cr	38.79	6.84%
DRREDDY	1185.00	₹98.91K Cr	148.68	1.75%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	69.40+81.4%	56.81	58.68	52.64	38.25	206.38
Other Income	1.17	2.87	0.68	1.73	0.66	5.93
Total Income	70.57+81.4%	59.68	59.36	54.36	38.91	212.31
Interest	0.41	0.90	0.39	0.24	0.28	1.81
Expenditure	-67.23-84.3%	-51.36	-55.53	-50.89	-36.48	-194.25
PBDT	0	0	0	0	0	0
EBITDA	3.30+17.0%	7.15	4.33	2.72	2.82	17.03
Depreciation	-0.72	-0.80	-0.79	-0.73	-0.77	-3.09
EBIT	2.58+25.9%	6.35	3.54	1.99	2.05	13.94
PBT	3.34+37.4%	8.32	3.83	3.47	2.43	18.06
Tax	-0.82	-2.46	-0.96	-0.91	-0.62	-4.94
Equity	16.60	16.60	0	0	16.60	16.60
OPM	4.73	13.94	6.53	6.60	6.25	8.51
Net Profit	2.52+38.5%	5.86	2.87	2.57	1.82	13.12
NPM	3.57	9.82	4.89	4.88	4.68	6.18
EPS	0.30+36.4%	0.71	0.35	0.31	0.22	1.58

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 17-18
Revenue	206.38+36.7%	150.94+4.2%	144.92	61.03
Other Income	5.93	2.69	2.13	0.91
Total Income	212.31+38.2%	153.63+4.5%	147.05	61.94
Expenditure	-194.25-38.6%	-140.13-3.3%	-135.71	-59.06
Interest	-1.81	-1.16	-0.82	-1.52
PBDT	0	0	0	2.88
EBITDA	17.03+13.5%	15+16.2%	12.91	4.50
Depreciation	-3.09	-3.03	-2.88	-1.01
EBIT	13.94+16.5%	11.97+19.3%	10.03	3.49
PBT	18.06+33.8%	13.50+19.0%	11.34	1.87
Tax	-4.94	-3.41	-3.04	-0.65
Equity	16.60	16.60	0	4.15
OPM (%)	8.51	8.79	8.00	4.72
Net Profit	13.12+30.0%	10.09+21.7%	8.29	1.22
NPM (%)	6.18	6.57	6.00	2.00
EPS (Rs)	1.58+29.5%	1.22+22.0%	1	3.65
CEPS	1.58	1.22	1	5.36

Metric	FY25-26
Revenue	206.38
Other Income	5.93
Total Income	212.31
Interest	1.81
Expenditure	-194.25
PBDT	0
EBITDA	17.03
Depreciation	-3.09
EBIT	13.94
PBT	18.06
Tax	-4.94
Equity	16.60
OPM	8.51
Net Profit	13.12
NPM	6.18
EPS	1.58

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25
Revenue	206.38+36.7%	150.94
Other Income	5.93	2.69
Total Income	212.31+38.2%	153.63
Expenditure	-194.25-38.6%	-140.13
Interest	-1.81	-1.16
PBDT	0	0
EBITDA	17.03+13.5%	15
Depreciation	-3.09	-3.03
EBIT	13.94+16.5%	11.97
PBT	18.06+33.8%	13.50
Tax	-4.94	-3.41
Equity	16.60	16.60
OPM (%)	8.51	8.79
Net Profit	13.12+30.0%	10.09
NPM (%)	6.18	6.57
EPS (Rs)	1.58+29.5%	1.22
CEPS	1.58	1.22

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

No dividend history.

Bonus

Year	Ratio	Ex-Date
2021	3:1	16 Nov 2021

Split

Year	Ratio	Ex-Date
2023	Rs.10/- to Rs.2/-	16 Mar 2023

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split